FDA News Digest
December 11, 2006
__________________________________________________________
IN THIS WEEK'S
ISSUE
» News
-- FDA Continues to Investigate Widespread E. Coli Outbreak
-- New Proposal Would Expand Experimental Drugs Availability
-- Companies Warned to Stop Compounding Anesthetic Creams
-- Latest 'Patient Safety News' Video Available Online
-- Deputy Commissioner Gottlieb Leaving FDA for Think Tank Job
» Recalls/Safety
Alerts
» Upcoming Public Meetings
» Question of the
Week
FDA has posted the latest edition of "Patient Safety News," a free Web-based video news program aimed primarily at health professionals. The program features information on new drugs, biologics, and medical devices, as well as FDA safety notifications and product recalls.
http://www.fda.gov/psn
Deputy Commissioner Gottlieb Leaving FDA for Think Tank Job
Scott Gottlieb, M.D., FDA deputy commissioner for medical and scientific affairs, will leave the agency Jan. 16 for a position in the American Enterprise Institute, a Washington-based think tank. While at FDA, Gottlieb has worked to improve the advisory committee process and the dissemination of risk information to the public.
http://www.fda.gov/opacom/hpnews.html.
To access the RSS feed of FDA news
releases, go to
http://www.fda.gov/bbs/topics/news/rssPress.xml.
[What is an RSS feed? See http://www.fda.gov/bbs/topics/news/newsfeeds.html.]
____________________________________________
For a list of recalls, market withdrawals, and safety
alerts involving
FDA-regulated
products from the past 60 days, go to http://www.fda.gov/opacom/7alerts.html.
To access the RSS feed of FDA recalls information, go
to
http://www.fda.gov/oc/po/firmrecalls/rssRecalls.xml
[What is an RSS feed? See http://www.fda.gov/bbs/topics/news/newsfeeds.html.]
_____________________________________________
RECENT SPEECHES
Dec. 5 --
FDA Deputy Commissioner for Medical and Scientific Affairs Scott Gottlieb, M.D., spoke before Windhover's FDA/CMS SummitSubject: health policy
To
view an archive of past speeches by FDA officials, go to
http://www.fda.gov/speeches/speechli.htm.
___________________________________________________
UPCOMING PUBLIC MEETINGS
Dec. 13 -- Psychopharmacologic Drugs Advisory Committee
Under discussion: Suicidality data from clinical trial of adult antidepressants
Location: Silver Spring, Md.
http://www.fda.gov/OHRMS/DOCKETS/98fr/E6-19248.htm
Dec. 14 -- Blood Products Advisory Committee
Under discussion: an emergency research study of bovine polymerized hemoglobin
Location: Silver Spring, Md.
http://www.fda.gov/OHRMS/DOCKETS/98fr/E6-20265.htm
Dec. 18 -- Public hearing to solicit comments on electronic submission of premarket material and other regulatory information
Location: Rockville, Md.
http://www.fda.gov/bbs/topics/NEWS/2006/NEW01510.html
Jan. 9 -- Public Workshop on Marketed Unapproved Drugs
Under discussion: how businesses can obtain FDA approval to legally market currently unapproved drug products
Location: Rockville, Md.
-- Press release: http://www.fda.gov/bbs/topics/NEWS/2006/NEW01500.html
-- Federal Register notice: http://www.fda.gov/OHRMS/DOCKETS/98fr/E6-17959.htm
For a list of FDA meetings, seminars, and other public events, go to
http://www.fda.gov/opacom/hpmeetings.html.
QUESTION OF THE WEEK
What is a stent?
A stent is a tiny, lattice-shaped, metal tube that is
inserted permanently into an artery. Drug-eluting stents are stents
that contain drugs to potentially
reduce the chance that arteries will
become blocked again.
Stents are used to hold open arteries that have become too narrow due to atherosclerosis, a condition in which plaque builds
up on the inner walls of arteries, the blood vessels that carry oxygen-rich
blood throughout the body. As artery walls thicken, the
pathway for blood narrows. This can slow or block blood
flow.
Stents act as a scaffold, remaining in place permanently to help keep arteries open so blood can flow.
Thanks for subscribing to FDA News Digest. Our next issue will be sent December 18.
Comments about FDA News Digest? Send an e-mail to fdanewsdigest@xxxxxxxxxv.
To subscribe to or unsubscribe
from this list, go to
__________________________________________________